NR 566 Week 2 Assignment; HIV National Curriculum - Antiretroviral Therapy

esson 1 Quiz: Antiretroviral Medications and Initial Therapy 1. Question: What result is required for maraviroc to be considered appropriate for use? 2. Question: Which one of the following medications requires phosphorylation to become active as an inhibitor of HIV? 3. Question: According to the Adult and Adolescent ARV Guidelines, at what CD4 threshold should antiretroviral therapy by recommended for persons with HIV? 4. Question: According to the Adult and Adolescent ARV Guidelines, which one of the following is classified as a recommended initial regimen for most people with HIV? 5. Question: After starting the antiretroviral therapy, when should the next HIV RNA level be checked? Lesson 2 Quiz: Adverse Effects of Antiretroviral Medications 1. Question: Which one of the following antiretroviral therapy regimens has been most clearly associated with weight gain? 2. Question: Which one of the following medications requires baseline HLA-B*5701 testing to identify persons at increased risk of developing a medication-related hypersensitivity reaction? 3. Question: Which organs are most likely to be adversely impacted by long-term tenofovir DF therapy 4. Question: What is the most likely explanation for this small, but persistent increase in serum creatinine? 5. Question: Atazanavir causes hyperbilirubinemia by inhibiting what enzyme? Lesson 3 Quiz: Drug Interactions with Antiretroviral Medications 1. Question: Which superfamily of enzymes is responsible for the metabolism of more than half of all antiretroviral medications? 2. Question: Which one of the following antiretroviral medications is most likely to have levels decreased if taken with a proton-pump inhibitor? 3. Question: What impact will this antiretroviral therapy switch likely have on methadone levels during the next 6 weeks? 4. Question: Which one of the following can be a serious complication of coadministration of ritonavir and inhaled fluticasone? 5. Question: Which one of the following antiretroviral medications should be avoided in a patient taking rifampin?